Views: 0 Author: Xiaoying Publish Time: 2026-09-22 Origin: Site
Test enzyme systems as systems: oral-care lactoperoxidase examples combine an enzyme, thiocyanate, and a peroxide source. Request a finished-formula catalytic assay, not only protein content or a raw-material CoA.[1]
Use 2 evidence layers for peptides: confirm the parent peptide with an appropriate identity/content method and review its degradation profile after justified stress. There is no universal “peptide-safe pH.”[2]
Screen 4 polyphenol stress vectors: oxygen, light, pH, and temperature can affect aqueous EGCG in published model systems. Compare the proposed package with a control and measure a named marker, not color alone.[3]
Separate 2 microbiology questions: routine microbial quality and preservative efficacy are different. ISO 11930:2019 addresses antimicrobial protection of water-miscible cosmetic products; it does not prove active retention or clinical performance.[4]
Approve 1 final system, not 3 isolated ingredients: a qualified private label mouthwash manufacturer should define the formula, test method, package, batch, and acceptance criteria before mass production.
It means managing three different evidence types in one water-based matrix. An enzyme may need a catalytic activity method. A peptide needs a fit-for-purpose identity and degradation profile. A polyphenol or botanical extract needs a named marker assay or chromatographic fingerprint.
Commercial mouthwashes use water–glycerine bases with ingredients such as surfactants, preservatives, flavours, colorants, and pH adjusters.[5] The brief should define one market, claim boundary, ingredient story, and evidence plan.
AI-generated illustration; not a Qiaoerna photograph, facility record, formula test, batch, certification, or release evidence.
See Qiaoerna’s Mouthwash OEM product range for category context.
Because the risk is in the bottle, not on the supplier certificate. A clear day-0 sample can still later show lost enzyme activity, peptide adsorption, polyphenol marker loss, haze, colour drift, off-notes, or package interaction.
Use three evidence layers: identity, the relevant quality signal (activity, parent/degradant profile, or marker/fingerprint), and complete-formula trend data in the proposed package.
Problem for brands: “active detected” may only mean that a non-specific method found something in a complex matrix.
OEM response: request method specificity, reference-standard traceability, recovery, repeatability, matrix blanks, and a summary of raw chromatograms or activity controls. A reported “pass” needs a stated method and pre-agreed criterion.
For wider supplier due diligence, read How to Choose the Right Mouthwash Manufacturer for Your Brand.
An enzyme can remain present while losing the catalytic function that made it commercially interesting. Treat pH, temperature history, surfactants, preservatives, salts, flavour materials, oxygen, and process order as variables to test—not as neutral background choices.
Lactoperoxidase (LPO) shows why. Reviewed oral-hygiene systems combine LPO with thiocyanate and a hydrogen-peroxide source, commonly through a peroxide-generating enzyme such as glucose oxidase.[1] Protein content alone therefore cannot show whether the complete system works in the rinse.
Ask for four records: the named enzyme and grade; an enzyme-specific activity assay with substrate and unit definition; the formula version; and the temperature–time/addition-order record.
Problem for brands: “cold process” is used as a slogan rather than a documented control.
OEM response: compare pilot variants that add the sensitive material at defined process points and choose the route using measured finished-matrix activity.
No single pH, preservative, or package is safe for every peptide. Aqueous-peptide literature identifies hydrolysis, deamidation, oxidation, aggregation, precipitation, and adsorption as potential failure pathways, with relevance depending on sequence and environment.[2]
Ask instead: how will this exact peptide be identified and trended in this exact mouthwash base? When it is the material of differentiation, use a qualified identity approach appropriate to the peptide.
Use a 2-part early control set: a finished formula containing the peptide and a justified matrix control. Compare parent-peptide recovery, related peaks or degradants, appearance, pH, and package-contact behaviour after defined stress. If a peptide function is commercially important, define a separate functional assay; do not infer function from a parent peak.
Problem for brands: a premium peptide is supported only by a “total protein” result.
OEM response: require an agreed identity/content method, a stability-indicating plan, and a written explanation of what each result does—and does not—demonstrate.
Polyphenols are formulation-active materials. Light, oxygen, pH, temperature, and trace metals can change the system. Protein–polyphenol interactions are a formulation risk signal; whether a proposed peptide blend is affected must be measured in that finished matrix. In one published aqueous EGCG study, both oxygen and sunlight affected stability, with oxygen more pronounced under that study’s conditions.[3] This is useful directionally, not a shelf-life claim for a mouthwash.
A plant-polyphenol/protein review describes pH-, salt-, and metal-relevant interactions.[6] In a combined rinse, marker loss, colour drift, haze, sediment, altered flavour, or changed enzyme/peptide recovery requires measurement, not guesswork.
Request three parallel checks: a named polyphenol marker or fingerprint; a physical profile covering colour, clarity/turbidity, sediment, and odour; and the relevant enzyme/peptide assay. Use the actual bottle and closure, and compare light exposure with a documented control.
Problem for brands: colour drift is treated as proof of marker loss—or a clear sample as proof of marker retention.
OEM response: trend named marker(s), appearance, and relevant enzyme/peptide method results in the same defined pack/stress study; interpret each result only within the stated method and acceptance criterion.
Use a 2-phase plan: prove formula compatibility first, then confirm final-pack behaviour. No universal test limit is given below; the criteria must be set for the ingredient, formula, method, market, and pack.
Decision gate | What the OEM should document | Why it matters |
|---|---|---|
Phase 1: Formula compatibility | Formula version, raw-material lots, appearance, pH at defined temperature, viscosity/density, active/marker method, matrix blanks, controlled stress design | Identifies day-0 incompatibility, assay interference, precipitation, and obvious sensory conflict |
Enzyme check | Identity plus catalytic activity method, substrate, unit definition, controls, process history | Avoids confusing “protein present” with retained function |
Peptide check | Parent identity/content, degradant profile, recovery, and justified adsorption/aggregation review | Exposes sequence change, loss, or container interaction |
Polyphenol check | Named-marker assay or fingerprint, colour/clarity trend, light/oxygen/pH comparison, botanical lot data | Avoids colour-only decisions and untracked extract variability |
Phase 2: Final pack | Exact bottle, closure, liner/pump, fill level, headspace, orientation, leak/closure review, storage record | Identifies package-driven light, oxygen, adsorption, leakage, or dispensing failures |
Microbiology and preservation | Routine microbiological-quality result plus a named preservative-efficacy protocol and interpretation | Separates batch quality from evidence of antimicrobial protection |
ISO 11930:2019 describes preservation-efficacy/microbiological-risk-assessment scope for water-soluble or water-miscible cosmetic products and notes that development methods may be adapted to defined objectives.[4] It is not an enzyme assay, peptide-stability test, polyphenol-marker test, or clinical-efficacy result.
For the commercial manufacturing model, see OEM vs. ODM Mouthwash: A Complete Guide for Private Label Buyers.
Ingredient research can direct formulation work; it does not authorize a finished-product claim. Classification and claim requirements depend on the formula, intended use, market, label language, and local rules. In the United States, particular anticaries claims and active ingredients for products applied topically to teeth can fall within a defined OTC-drug framework; that is not a shortcut for positioning any functional rinse as OTC.[7]
Use technical language such as contains a named botanical extract, evaluated for colour and marker retention under the stated protocol, or tested in the proposed package under the stated conditions. Avoid treatment, prevention, cure, repair, microbiome-restoration, or disease-control claims unless the final product, evidence, and regulatory pathway have been independently assessed for the target market.
Problem for brands: an ingredient study is copied into a product claim before the product itself has been tested.
OEM response: keep a claim-to-evidence file identifying the exact formula, pack, test method, market, and approved wording.
For EU-market preparation, use Qiaoerna’s EU Private Label Mouthwash Compliance Guide as a starting point, not a substitute for product-specific review.
A sample dossier should prove that the featured materials and the finished matrix were measured together. Before approval, request these 8 evidence items:
Method suitability, including matrix blanks, reference-standard traceability, recovery, and repeatability.
Enzyme-specific catalytic activity method, substrate, unit definition, and controls where an enzyme is featured.
Peptide identity/content and degradation approach appropriate to the selected material.
Polyphenol marker assay or fingerprint with botanical traceability where relevant.
Defined stress conditions, timepoints, formula controls, and the data trended at each point.
Formula version, ingredient lots, process temperature–time profile, addition order, and fill conditions.
Final-pack configuration and compatibility data for the proposed bottle, closure, headspace, and fill level.
A clear statement separating observations, provisional targets, market requirements, and claims evidence.
At Qiaoerna, start with the sample evidence needed for your formula and market. Share the ingredient concept, format, package direction, and claim boundary to scope compatibility screening and sample documentation. Contact the team through the oral-care manufacturing home page or at admin@qiaoerna.com.cn.
It can be explored, but it should not be combined only for label appeal. Define identity, activity or marker methods, compatibility, sensory checks, preservation approach, and package evaluation for the exact blend first.
MOQ depends on formula, ingredient sourcing, bottle, closure, decoration, testing scope, and market. Request tiered quotations only after formula and package direction are defined.
Timing depends on whether the project uses an existing base or needs compatibility screening, method work, package testing, and claim review. Ask the OEM to separate initial lab-sample timing from evidence-generation timing.
It should identify formula version, raw-material lots, sample batch, package, test methods, conditions, results, deviations, and the status of each result: observation, provisional target, or release evidence.
Yes, but define botanical identity, plant part, extraction/carrier, fingerprint or named marker, lot CoA, and the plan for colour, clarity, odour, and marker control in the final rinse.
Requirements depend on the market and classification. Start with relevant facility-quality documentation, ingredient CoAs/SDS where applicable, formula and batch traceability, microbiological and stability records, package data, and market-specific files.
Confirm lead time only after formula freeze, packaging procurement, label approval, testing requirements, and capacity are aligned. Ask for raw-material, packaging, filling, review, and release timing separately.
A functional rinse is credible when its claims and sample evidence travel together. Enzyme systems need activity evidence; peptides need identity and degradation control; polyphenols need marker, appearance, sensory, and package-aware evaluation. The right OEM turns that evidence into a documented final-matrix decision before scale-up.
[1] Magacz M, Kędziora K, Sapa J, Krzyściak W. (2019). “The Significance of Lactoperoxidase System in Oral Health: Application and Efficacy in Oral Hygiene Products.” International Journal of Molecular Sciences, 20(6), 1443. PMID: 30901933. DOI: 10.3390/ijms20061443.
Key finding: explains lactoperoxidase system components and formulation-relevant cofactor logic; it does not establish a universal mouthwash specification.
[2] Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schöneich C, Avanti C. (2023). “Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.” Pharmaceutics, 15(3), 935. PMID: 36986796. DOI: 10.3390/pharmaceutics15030935.
Key finding: reviews aqueous-peptide degradation pathways and the sequence-specific importance of pH, buffer, oxygen, temperature, and excipients.
[3] Zeng J, Xu H, Cai Y, et al. (2018). “The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate.” Molecules, 23(9), 2394. PMID: 30231585. DOI: 10.3390/molecules23092394.
Key finding: in an aqueous EGCG model, oxygen and sunlight affected EGCG stability; the tested conditions are not a finished-mouthwash shelf-life claim.
[4] International Organization for Standardization. (2019). “ISO 11930:2019 Cosmetics—Microbiology—Evaluation of the antimicrobial protection of a cosmetic product.” Official record.
Regulatory basis: identifies preservation-efficacy/microbiological-risk-assessment scope for cosmetic products, including water-miscible products; it does not test featured-active retention.
[5] Radzki D, Wilhelm-Węglarz M, Pruska K, Kusiak A, Ordyniec-Kwaśnica I. (2022). “A Fresh Look at Mouthwashes—What Is Inside and What Is It For?” International Journal of Environmental Research and Public Health, 19(7), 3926. PMID: 35409608. DOI: 10.3390/ijerph19073926.
Key finding: surveys typical mouthwash vehicle and excipient architecture, supporting a complete-matrix compatibility approach.
[6] Tazeddinova D, Rahman MR, Hamdan SB, et al. (2022). “Plant based polyphenol associations with protein: A prospective review.” BioResources, 17(4), 7110–7134. Open article.
Key finding: reviews pH- and salt-dependent protein–polyphenol interactions and oxidative quinone routes; these are compatibility mechanisms, not mouthwash efficacy claims.
[7] U.S. Electronic Code of Federal Regulations. “21 CFR Part 355—Anticaries Drug Products for Over-the-Counter Human Use.” Current eCFR text.
Regulatory basis: illustrates that particular anticaries treatment-rinse claims and ingredients can sit within a defined OTC-drug framework; classification is product- and market-specific.
Author: Xiaoying, Research & Development Lead, Qiaoerna. Technical review: Qiaoerna Quality & Regulatory Review Team. This article is technical B2B education, not regulatory advice or a finished-product efficacy claim.

